ArticleFrontiers in psychiatry2024
Establishment and validation a relapse prediction model for bipolar disorder.
Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and safety of adjunctive transcranial alternating current stimulation in bipolar depression: A randomized controlled trial.Molecular psychiatry · 2026Article
- Telepsychiatry and Artificial Intelligence: A Structured Review of Emerging Approaches to Accessible Psychiatric Care.Healthcare (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The recurrence rate of bipolar disorder (BD) is relatively high. Assessing the risk of relapse in patients with BD can assist in identifying populations at high risk for recurrence, and early feasible interventions can improve patient' prognoses. Therefore, it is important to establish and validate predictive models for relapse risk in patients with BD. Method: We used 303 patients with BD admitted to the Anhui Mental Health Center as a retrospective training cohort and 81 patients from the Wuhu Fourth People's Hospital as an external validation cohort. We collected a multidimensional assessment of the characteristics of patients eligible for enrollment, including general demographic characteristics, medical history, treatment, and assessment of selected scales. At the same time, they were followed up for 1 year after reaching the recovery standard after treatment. Depending on whether their symptoms returned within a year, patients with BD were divided into recurrent and non-recurrent groups. Recurrence risk factors for BD were selected using univariate and binary logistic regression analyses based on the clinical data of the patients and other pertinent information. A nomogram model was developed to predict the incidence of BD relapse. To further assess the model fit and dependability, calibration curves, working curves of subject attributes, and decision curves were also employed. Result: A total of 384 patients with BD were enrolled in this study, of whom 250(65.1%) had non-recurrent episodes and 134(34.9%) had recurrent episodes. Of these, 96 (31.7%) had relapses at the Anhui Mental Health Centre and 38 (46.9%) at the Fourth People's Hospital of Wuhu City. According to the results of univariate and multivariate logistic regression analyses, the number of prior episodes (odds ratio [OR]: 1.38, 95% confidence interval [CI]: 1.179-1.615), Social Disability Screening Schedule (SDSS) score (OR: 1.303, 95% CI: 1.027-1.652), Pittsburgh Sleep Quality Index (PSQI) (OR: 1.476, 95% CI: 1.29-1.689), Number of visits(OR: 0.768, 95% CI: 0.684-0.863), suicidal behaviors (OR: 5.54, 95% CI: 1.818-16.881) and the electroconvulsive therapy (ECT) (OR: 0.382, 95% CI: 0.156-0.94) were independent risk factors for relapse in patients with BD. An analysis of the receiver operating characteristic curve, calibration curve, and clinical decision curve further revealed that the predictive efficiency and degree of fit between the predicted value of the nomogram and the actual observed value were better. Conclusion: This study found that the number of previous episodes, SDSS score, PSQI score and suicidal behaviors were independent risk factors for relapse of BD, while the number of visits and ECT were protective factor. Based on these factors, we developed and validated a nomogram for predicting relapse in patients with BD; that has clinical reference values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.